Significant movement in price has been observed in Vivimed Labs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Vivimed Labs Limited has submitted their response.
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
NSE flagged a significant movement in Vivimed Labs' share price across exchanges and sought clarification from the company. In its response dated January 6, 2026, Vivimed Labs stated it has no undisclosed price-sensitive information or pending announcement under SEBI's Listing Regulations that could explain the price movement. The company attributed the price swing purely to market conditions and general market dynamics. It also reiterated its commitment to disclose any material information to the exchanges as required under Regulation 30 of SEBI LODR Regulations, 2015.
This is a routine exchange surveillance query and the company's standard denial response, so there is no new fundamental information for shareholders. However, the fact that NSE had to seek clarification means the stock saw unusual volatility, which investors should monitor closely for any further disclosures or price swings.